U.S. Food And Drug Administration Approved A Second Covid-19 Vaccine. The Vaccine Has Been Known As The Moderna Covid-19 Vaccine; The Approved Vaccine Will Be Marketed As Spikevax For The Prevention Of Covid-19 In Individuals 18 Years Of Age And Older.Key Points:Spikevax Meets The Fda
